Received May 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | W029538 | — |
no side effects or other symptoms; Medical Assistant reports MMRII expired 9/15/2024 and was administered to a patient on 4/12/2025. No previous temperature excursion, n; This spontaneous report was received from an Other health professional (medical assistatn) and refers to a female patient of unknown age. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 12-Apr-2025, the patient started therapy with an expired dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), injection, lot #W029538 was confirmed to be valid, expiration date reported and confirmed as 15-SEP-2024, 0.5 mL (route and site of administration not provided)for prophylaxis (expired product administered); administered with sterile diluent (MERCK STERILE DILUENT) (strength dose, route and site of administration, lot # and expiration date were not reported). There were no previous temperature excursion, no side effects or other symptoms (no adverse event).
Sterile diluent